Summary
- Current Price
- As of today, BIOA price is $16.68, up +0.36% on
- Current Price All-Time High
- BIOA price is currently -37.34% below its historical high of $26.62 set on
- Market Cap
- BIOA current market cap is $741M, up +422.96% over the past 365 days
- PE Ratio
- BIOA PE ratio is unknown
- Revenue
- BIOA current annual revenue is $9.00M, up +100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for BIOA has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | BioAge Labs, Inc. |
| Ticker | NASDAQ: BIOA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | bioagelabs.com |
| Employees | 62 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $16.68 | |
| Price, 1D Change | +0.36% | |
| $741M | ||
| - | ||
| - | ||
| 1.41 | ||
| $9M | ||
| Revenue, 1Y Change | +100.00% | |
| -$2.24 | ||
| EPS, 1Y Change | -13.09% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.24 | ||
| EPS Estimate | N/A | -$2.60 |
| EPS Est. Change | N/A | -15.90% |
| $9.00M | ||
| Revenue Estimate | N/A | $72.41M |
| Revenue Est. Change | N/A | +705.00% |
| Current Price | $16.68 | |
| Price Target | - | $56.00 |
| Price Tgt. Change | - | +235.73% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.35 | -$1.98 | +40.87% | |
| -$2.19 | -$2.24 | -2.27% | |
| -$2.60 | N/A | -15.90% | |
| -$2.78 | N/A | -23.76% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $7.11M | $9.00M | +26.45% | |
| $72.41M | N/A | +705.00% | |
| $19.11M | N/A | +112.42% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $16.68 | |
| $12.01 | ||
| SMA 200 vs Price | -28.02% | |
| $18.58 | ||
| SMA 50 vs Price | +11.38% | |
| 1.41 | ||
| $1.20 | ||
| 43.57 | ||
| 56.55% | ||
| 79.83% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $9.00M | ||
| -$2.24 | ||
| $8.78M | ||
| 97.63% | ||
| -$92.78M | ||
| -1,031.46% | ||
| -$80.61M | ||
| -896.11% | ||
| -$92.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 14.24 | ||
| 14.24 | ||
| - | ||
| - | ||
| 17.42 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 82.33 | ||
| 2.72 | ||
| -5.02 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $272.05M | ||
| $281.10M | ||
| $295.53M | ||
| $286.79M | ||
| $23.48M | ||
| $20.14M | ||
| $5.56M | ||
| $3.23M | ||
| $2.67M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $89.60M | ||
| $101.56M | ||
| $213.00K | ||
| $0.00 | ||
| $213.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$81.63M | ||
| -$95.22M | ||
| $11.47M | ||
| $719.00K | ||
| -$82.35M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Needham | ||
| Citigroup | → | |
| Oppenheimer | ||
| Jefferies | → | |
| Piper Sandler | ||
| Morgan Stanley | → | |
| Citigroup | → | |
| Citigroup | → | |
| Citigroup | → | |
| William Blair |
Analyst sentiment
Institutional ownership
Screeners with BIOA
FAQ
What is the ticker symbol for BioAge Labs, Inc.?
The ticker symbol for BioAge Labs, Inc. is NASDAQ:BIOA
Does BioAge Labs, Inc. pay dividends?
No, BioAge Labs, Inc. does not pay dividends
What sector is BioAge Labs, Inc. in?
BioAge Labs, Inc. is in the Healthcare sector
What industry is BioAge Labs, Inc. in?
BioAge Labs, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is BioAge Labs, Inc. based in?
BioAge Labs, Inc. is headquartered in United States
When did BioAge Labs, Inc. go public?
BioAge Labs, Inc. initial public offering (IPO) was on September 26, 2024
Is BioAge Labs, Inc. in the S&P 500?
No, BioAge Labs, Inc. is not included in the S&P 500 index
Is BioAge Labs, Inc. in the NASDAQ 100?
No, BioAge Labs, Inc. is not included in the NASDAQ 100 index
Is BioAge Labs, Inc. in the Dow Jones?
No, BioAge Labs, Inc. is not included in the Dow Jones index
When was BioAge Labs, Inc. last earnings report?
BioAge Labs, Inc.'s most recent earnings report was on May 5, 2026
When does BioAge Labs, Inc. report earnings?
The date for BioAge Labs, Inc.'s next earnings report has not been announced yet
Data Sources & References
- BIOA Official Website bioagelabs.com
- BIOA Profile on Yahoo Finance finance.yahoo.com/quote/BIOA
- BIOA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bioa